Descargar PDF

Otros usuarios también vieron estos artículos

Pembrolizumab-induced dual endocrine disruption: A case report María Carmen Dameto Pons; Elena González Arnáiz; María Antequera González; Xavier F. Pérez Candel; Diana Ariadel Cobo; Javier Castañón Alonso; María D. Ballesteros Pomar;
10.1016/j.endinu.2025.501630
Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves¿ disease Melina Saban; Melisa Costilla; Alicia Juana Klecha; Mariana Di Cugno; Marina Inés Curria; Graciela Cremaschi; María Laura Barreiro Arcos;
Endocrinol Diabetes Nutr. 2022;69:409-17
Follow-up of infants born to mothers with Graves¿ disease Cristiana Maximiano; Marta Ribeiro Silva; Fábia Carvalho; Juliana Almeida; Maria Miguel Gomes; Sofia Martins; Olinda Marques; Alexandra Estrada; Almerinda Pereira; Ana Antunes;
Endocrinol Diabetes Nutr. 2021;68:472-80